Nanalysis Scientific Balance Sheet Health
Financial Health criteria checks 3/6
Nanalysis Scientific has a total shareholder equity of CA$11.3M and total debt of CA$17.0M, which brings its debt-to-equity ratio to 150.8%. Its total assets and total liabilities are CA$37.1M and CA$25.9M respectively.
Key information
150.77%
Debt to equity ratio
CA$16.97m
Debt
| Interest coverage ratio | n/a |
| Cash | CA$410.00k |
| Equity | CA$11.26m |
| Total liabilities | CA$25.85m |
| Total assets | CA$37.11m |
Recent financial health updates
Nanalysis Scientific (CVE:NSCI) Is Carrying A Fair Bit Of Debt
Oct 22
Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?
Oct 28We Think Nanalysis Scientific (CVE:NSCI) Has A Fair Chunk Of Debt
Jan 31Would Nanalysis Scientific (CVE:NSCI) Be Better Off With Less Debt?
Aug 26Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?
Dec 08Is Nanalysis Scientific (CVE:NSCI) Weighed On By Its Debt Load?
Jul 15Recent updates
Nanalysis Scientific (CVE:NSCI) Is Carrying A Fair Bit Of Debt
Oct 22Investors Holding Back On Nanalysis Scientific Corp. (CVE:NSCI)
Aug 30Nanalysis Scientific Corp.'s (CVE:NSCI) Price Is Right But Growth Is Lacking
Apr 18The Market Doesn't Like What It Sees From Nanalysis Scientific Corp.'s (CVE:NSCI) Revenues Yet As Shares Tumble 25%
Dec 14Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?
Oct 28Nanalysis Scientific Corp.'s (CVE:NSCI) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 19Nanalysis Scientific Corp. (CVE:NSCI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
May 12Benign Growth For Nanalysis Scientific Corp. (CVE:NSCI) Underpins Stock's 25% Plummet
Mar 24Nanalysis Scientific Corp. (CVE:NSCI) Shares Fly 43% But Investors Aren't Buying For Growth
Feb 08We Think Nanalysis Scientific (CVE:NSCI) Has A Fair Chunk Of Debt
Jan 31Would Nanalysis Scientific (CVE:NSCI) Be Better Off With Less Debt?
Aug 26Nanalysis Scientific Corp.'s (CVE:NSCI) Price Is Right But Growth Is Lacking
Apr 17Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?
Dec 08Is Nanalysis Scientific (CVE:NSCI) Weighed On By Its Debt Load?
Jul 15Health Check: How Prudently Does Nanalysis Scientific (CVE:NSCI) Use Debt?
Jan 24Is Nanalysis Scientific (CVE:NSCI) Using Debt Sensibly?
Mar 29Nanalysis Scientific (CVE:NSCI) Has Debt But No Earnings; Should You Worry?
Dec 14
Financial Position Analysis
Short Term Liabilities: NSCI's short term assets (CA$15.0M) do not cover its short term liabilities (CA$17.5M).
Long Term Liabilities: NSCI's short term assets (CA$15.0M) exceed its long term liabilities (CA$8.3M).
Debt to Equity History and Analysis
Debt Level: NSCI's net debt to equity ratio (147.1%) is considered high.
Reducing Debt: NSCI's debt to equity ratio has increased from 20.1% to 150.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable NSCI has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: NSCI is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 4.6% per year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/08 02:46 |
| End of Day Share Price | 2026/02/06 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Nanalysis Scientific Corp. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Douglas Loe | Leede Financial Inc |
| Max Czmielewski | Ventum Financial Corp |